1. Home
  2. Live Updates
  3. Michaelj labarre

Live Breaking News & Updates on Michaelj labarre

Stay informed with the latest breaking news from Michaelj labarre on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Michaelj labarre and stay connected to the pulse of your community

Halozyme Therapeutics (NASDAQ:HALO) Updates FY 2024 Earnings Guidance

Halozyme Therapeutics (NASDAQ:HALO) Updates FY 2024 Earnings Guidance
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Japan , Switzerland , Belgium , United-states , Michaelj-labarre , Halozyme-therapeutics-company-profile , Securities-exchange-commission , Halozyme-therapeutics-inc , Halozyme-therapeutics , Get-free-report , Moderate-buy

Halozyme Therapeutics (NASDAQ:HALO) Trading Up 5.9%

Halozyme Therapeutics (NASDAQ:HALO) Trading Up 5.9%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states , Japan , Belgium , Switzerland , Michaelj-labarre , Rise-advisors , Halozyme-therapeutics-company-profile , Securities-exchange-commission , Goldman-sachs-group , Fidelis-capital-partners , Halozyme-therapeutics-inc

Halozyme Therapeutics (NASDAQ:HALO) Given "Buy" Rating at HC Wainwright

Halozyme Therapeutics (NASDAQ:HALO) Given "Buy" Rating at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Japan , Switzerland , Belgium , United-states , Michaelj-labarre , Nasdaq , Principal-securities-inc , Halozyme-therapeutics-inc , First-horizon-advisors-inc , Rise-advisors , Goldman-sachs-group

Halozyme Therapeutics (NASDAQ:HALO) Issues FY24 Earnings Guidance

Halozyme Therapeutics (NASDAQ:HALO) Issues FY24 Earnings Guidance
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Belgium , Japan , United-states , Switzerland , Michaelj-labarre , Halozyme-therapeutics-inc , Halozyme-therapeutics-company-profile , Halozyme-therapeutics , Get-free-report , Moderate-buy , Halozyme-therapeutics-daily

Halozyme Therapeutics (NASDAQ:HALO) Releases FY24 Earnings Guidance

Halozyme Therapeutics (NASDAQ:HALO) Releases FY24 Earnings Guidance
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Japan , United-states , Belgium , Michaelj-labarre , Halozyme-therapeutics-inc , Nasdaq , Halozyme-therapeutics , Get-free-report , Moderate-buy , Halozyme-therapeutics-daily

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Gallacher Capital Management LLC

Gallacher Capital Management LLC boosted its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 85.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,403 shares of the biopharmaceutical company’s stock after acquiring an additional 5,245 shares during the period. […]

United-states , Switzerland , Japan , Belgium , Michaelj-labarre , Halozyme-therapeutics-company-profile , Allspring-global-investments-holdings , Goldman-sachs-group , Gallacher-capital-management , Halozyme-therapeutics-inc , Hsbc-holdings

Halozyme Therapeutics (NASDAQ:HALO) Earns "Buy" Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Tuesday, Benzinga reports. HC Wainwright currently has a $50.00 price target on the biopharmaceutical company’s stock. HALO has been the topic of a number of other reports. The Goldman Sachs Group dropped their price objective […]

Switzerland , Washington , United-states , Belgium , Japan , Michaelj-labarre , Securities-exchange-commission , Mirae-asset-global-investments-co , Nasdaq , Washington-capital-management-inc , Exchange-traded-concepts

HC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They presently have a $50.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 27.23% from the company’s […]

Japan , United-states , Belgium , Switzerland , Michaelj-labarre , Hsbc-holdings , Allspring-global-investments-holdings , Halozyme-therapeutics-inc , International-assets-investment-management , Goldman-sachs-group , Harvey-capital-management-inc

Zacks Research Comments on Halozyme Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:HALO)

Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) – Investment analysts at Zacks Research lifted their FY2026 earnings per share estimates for Halozyme Therapeutics in a research report issued to clients and investors on Monday, April 22nd. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will post earnings of $5.16 per share for […]

Japan , United-states , Belgium , Switzerland , Michaelj-labarre , Commonwealth-equity-services , Vontobel-holding-ltd , Goldman-sachs-group , Halozyme-therapeutics-company-profile , Linden-thomas-advisory-services , Exchange-traded-concepts

Duality Advisers LP Increases Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Duality Advisers LP Increases Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Japan , Switzerland , Belgium , United-states , Michaelj-labarre , Exchange-commission , Morgan-stanley , Securities-exchange-commission , Halozyme-therapeutics-inc , Holdings-channel , Alliance-wealth-advisors